zaleplon has been researched along with carbazeran in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albaugh, D; Fisher, MB; Fullenwider, CL; Hutzler, JM; Schmenk, J; Yang, YS | 1 |
Obach, RS; Orozco, CC; Strelevitz, TJ | 1 |
Bailey, S; Baxi, SM; Cheng, H; Goulet, L; Guo, L; Hoffman, J; Jiang, Y; Johnson, TO; Johnson, TW; Knighton, DR; Li, C; Li, J; Liu, KK; Liu, Z; Marx, MA; Walls, M; Wells, PA; Yin, MJ; Zhu, J; Zientek, M | 1 |
3 other study(ies) available for zaleplon and carbazeran
Article | Year |
---|---|
Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
Topics: Aldehyde Oxidase; Algorithms; Animal Use Alternatives; Cells, Cultured; Cryopreservation; Cytosol; Drug Evaluation, Preclinical; Enzyme Inhibitors; Enzyme Stability; Hepatocytes; Humans; Hydralazine; Intestinal Mucosa; Kinetics; Oxidation-Reduction; Pharmaceutical Preparations; Substrate Specificity | 2012 |
Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
Topics: Acetamides; Aldehyde Oxidase; Cryopreservation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytosol; Enzyme Activation; Hepatocytes; Humans; Hydralazine; Liver; Microsomes, Liver; Pyrimidines | 2012 |
Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design.
Topics: | 2013 |